Kamlesh Haribhakti
EVP & CSO, Director
pharmaceutical
VENUS PHARMA GmbH
Iraq
Biography
"Mr. Haribhakti has extensive experience in all aspects of pharmaceutical development including formulations, analytical, pharmacokinetics, and regulatory. Mr. Haribhakti has been responsible for successfully developing, filing, and obtaining FDA approval for over 100 generic pharmaceutical products. Previously, Mr. Haribhakti was Managing Director of Dinesh Remedies Limited (DRL). Prior to DRL, Mr. Haribhakti was a Co-Founder and Chief Executive Officer of KVD Pharma until its sale to Amneal Pharmaceuticals in Dec. 2007. He has also served in R&D roles for several pharmaceutical companies throughout his career including Able Laboratories, Inc., McNeil Pharmaceuticals (a Johnson & Johnson company), Eon Laboratories, Inc. (now Sandoz, a Novartis Company), Faulding/Purepac Pharmaceutical Company (now Actavis, Inc.), and Ivax Pharmaceuticals, Inc. (now Teva Pharmaceuticals Industries Limited). "
Research Interest
pharmaceutical science
